Randal M. Bugianesi
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Ion channel regulation and function, Cardiac electrophysiology and arrhythmias, Nicotinic Acetylcholine Receptors Study, Neuroscience and Neuropharmacology Research, Pain Mechanisms and Treatments
Most-Cited Works
- → Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo(1997)218 cited
- → Blockers of the Delayed-Rectifier Potassium Current in Pancreatic β-Cells Enhance Glucose-Dependent Insulin Secretion(2006)165 cited
- → Subunit Composition of Brain Voltage-gated Potassium Channels Determined by Hongotoxin-1, a Novel Peptide Derived fromCentruroides limbatus Venom(1998)126 cited
- → Modified in vivo behavior of liposomes containing synthetic glycolipids(1981)107 cited
- → Expression of Voltage-Gated Potassium Channels in Human and Rhesus Pancreatic Islets(2004)106 cited
- → Analgesic Effects of a Substituted N-Triazole Oxindole (TROX-1), a State-Dependent, Voltage-Gated Calcium Channel 2 Blocker(2010)97 cited
- → Identification and Biochemical Characterization of a Novel Nortriterpene Inhibitor of the Human Lymphocyte Voltage-Gated Potassium Channel, Kv1.3(1999)95 cited
- → Characterization of the Substituted N-Triazole Oxindole TROX-1, a Small-Molecule, State-Dependent Inhibitor of Cav2 Calcium Channels(2011)66 cited
- → Identification of a New Class of Inhibitors of the Voltage-Gated Potassium Channel, Kv1.3, with Immunosuppressant Properties(2002)64 cited
- → A High-Throughput Assay for Evaluating State Dependence and Subtype Selectivity of Cav2 Calcium Channel Inhibitors(2008)58 cited